Pasadena, CA, September 6, 2023 // – Deep 6 AI, the leading AI-powered clinical trial acceleration software, announces the launch of its genomics module to accelerate enrollment for precision medicine and oncology research. Now, healthcare organizations and life sciences companies can precision-match patients to clinical trials based on their complete clinical and genomic profile, improving trial design, feasibility, and recruitment. Deep 6 AI’s CEO, Wout Brusselaers, commented: “Genetic markers often determine a patient’s eligibility for precision medicine and oncology clinical trials. But most of the salient genomics data is scattered across the EMR, requiring manual and time-consuming chart reviews that delay enrollment. Applying our AI to genomics data will accelerate and de-risk research and bring life-changing therapies to patients faster.”Learn more about the Deep 6 AI genomics module here.